Second Line Treatments in Advanced Platinum-Resistant Non Small Cell Lung Cancer. A Critical Review of Literature

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|4|1|27-33

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.4, Iss.1, 2009-01, pp. : 27-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 12, 2008-11 ,pp. : 665-670

Karger

Access to resources Recommend Favorite

Bevacizumab in combination with different platinum‐based doublets in the first‐line treatment for advanced nonsquamous non‐small‐cell lung cancer: A network meta‐analysis

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1676-1688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 238-246

Karger

Access to resources Recommend Favorite

Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 2, 2010-05 ,pp. : 103-111

Bentham Science Publishers

Access to resources Recommend Favorite